MAPT and Alzheimer disease: Data from a mouse model of AD showed decreased gamma before the cognitive decline and photo-stimulation of modified cells with blue light at 40 Hz resulted in a significant increase in Aβ42 clearance and p-tau reduction in CA1 of the hippocampus (Iaccarino et al., 2016).